ALGS vs K · rev $3.6M vs P/E 23, $29.03B cap
Aligos Therapeutics Inc (ALGS) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
K does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the ALGS and K stock pages for the full models.
Not investment advice.